Financing type:  underwritten prospectus offering

Gross proceeds:  $10,002,800

Offering:  2,942,000 listed shares

Offering price:  $3.40 per listed share

Overallotment option:  The underwriters had an option to purchase a maximum of 441,300 listed shares for overallotment purposes. As of March 13, 2026, such option has expired without being exercised and no listed shares have been issued thereunder.

Disclosure:  Refer to the prospectus supplement to the short form base shelf prospectus dated Jan. 23, 2026, and the company's news releases dated Jan. 21, 2026, and Jan. 29, 2026.